Skip to content

Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter

Evaluation of the Safety and Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter for Peripheral Intravenous (PIV) Insertion in Children, Oncology Patients and Elderly: a Controlled Randomized Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00914069
Enrollment
175
Registered
2009-06-04
Start date
2009-06-30
Completion date
2013-08-31
Last updated
2017-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Access Complication

Brief summary

The study will test a hypothesis that the RIVS system will have a higher rate of successful first PIV placement compared to conventional catheter without a significant increase in complications and time of procedure.

Detailed description

The hypothesis to be statistically tested was that the RIVS system will have a higher rate of successful first attempt peripheral intravenous placement success as compared to conventional peripheral intravenous catheters without a significant increase in device related complications and procedure time.

Interventions

DEVICERIVS vascular access

Access to peripheral vasculature

DEVICEConventional vascular access

Vascular access using conventional venous access device

Sponsors

C. R. Bard
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Any type of oncology patients undergoing chemotherapy or post-chemotherapy (without a port/cannula), or over 65 years * Requires peripheral IV as determined by examining physician * Requires the IV when a study nurse or resident is available * Able to sign an informed consent

Exclusion criteria

* Active systemic or cutaneous infection or inflammation; * Pre-existing immunodeficiency disorder and/or chronic use of systemic steroids; * Known, significant history of bleeding diathesis, coagulopathy, von Willebrand's disease or current platelet count \< 100,000 cells/mm3, baseline International Normalized Ratio (INR) ≥1.8, or fibrinogen level less than 150 mg/dl (if received a fibrinolytic agent within prior 24 hours); * Currently involved in any other investigational clinical trials; * Previous vascular grafts or surgery at the target vessel access site; * Females who are pregnant, planning to become pregnant within 3 months of the procedure, or lactating; * Central line available * Requirement for immediate IV placement (patient's condition would potentially be compromised if there is a time delay in IV placement)

Design outcomes

Primary

MeasureTime frameDescription
IV Insertion Success Rate at First Attempt IV Insertion Success Rate at First AttemptAn access attempt usually ranges from 0 to 45 minutes in duration.A successful IV insertion includes all of the following: initial vein penetration, which is visualized by a flash back of blood into the access device, deployment of the guidewire, advancement of the catheter into the vein, retraction of needle and guidewire, and flushing of IV. A secured flushed IV will be indicative of a successful PIV placement.
Summary of Major ComplicationsPost-PIV placement until catheter removal (usually within 4 days)Any device-related or procedure-related adverse event that causes clinically consequential symptoms to the patient. These may include access site hematoma, bleeding, infection, nerve injury, vessel laceration, wound dehiscence, allergic reaction, or inflammation, among others.

Secondary

MeasureTime frameDescription
Time Required to Obtain AccessAn access attempt usually ranges from 0 to 45 minutes in duration.A secured flushed IV will be indicative of a successful PIV placement.
Second Stick Success RateAn access attempt usually ranges from 0 to 45 minutes in duration.A secured flushed IV will be indicative of a successful PIV placement.
Summary of Minor ComplicationsPost-PIV placement until catheter removal (usually within 4 days)Any device-related or procedure-related adverse event that causes clinically inconsequential symptoms to the patient.

Countries

United States

Participant flow

Pre-assignment details

Prior to assignment to groups, two subjects withdrew from the study. Also prior to group assignment, one subject did not have a consent form and was excluded from the study.

Participants by arm

ArmCount
RIVS Vascular Access
RIVS vascular access RIVS vascular access: Access to peripheral vasculature
84
Conventional Vascular Access
Conventional vascular access Conventional vascular access: Vascular access using conventional venous access device
88
Total172

Baseline characteristics

CharacteristicRIVS Vascular AccessConventional Vascular AccessTotal
Age, Continuous66.1 years
STANDARD_DEVIATION 9.4
67.2 years
STANDARD_DEVIATION 10.9
66.7 years
STANDARD_DEVIATION 10.2
Race/Ethnicity, Customized
Asian
14 participants16 participants30 participants
Race/Ethnicity, Customized
Black
10 participants10 participants20 participants
Race/Ethnicity, Customized
Hispanic
10 participants7 participants17 participants
Race/Ethnicity, Customized
Other
8 participants9 participants17 participants
Race/Ethnicity, Customized
White
42 participants44 participants86 participants
Sex: Female, Male
Female
36 Participants49 Participants85 Participants
Sex: Female, Male
Male
48 Participants37 Participants85 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
1 / 840 / 88
serious
Total, serious adverse events
0 / 840 / 88

Outcome results

Primary

IV Insertion Success Rate at First Attempt IV Insertion Success Rate at First Attempt

A successful IV insertion includes all of the following: initial vein penetration, which is visualized by a flash back of blood into the access device, deployment of the guidewire, advancement of the catheter into the vein, retraction of needle and guidewire, and flushing of IV. A secured flushed IV will be indicative of a successful PIV placement.

Time frame: An access attempt usually ranges from 0 to 45 minutes in duration.

ArmMeasureValue (NUMBER)
RIVS Vascular AccessIV Insertion Success Rate at First Attempt IV Insertion Success Rate at First Attempt60 participants
Conventional Vascular AccessIV Insertion Success Rate at First Attempt IV Insertion Success Rate at First Attempt51 participants
p-value: 0.05Fisher Exact
Primary

Summary of Major Complications

Any device-related or procedure-related adverse event that causes clinically consequential symptoms to the patient. These may include access site hematoma, bleeding, infection, nerve injury, vessel laceration, wound dehiscence, allergic reaction, or inflammation, among others.

Time frame: Post-PIV placement until catheter removal (usually within 4 days)

ArmMeasureValue (NUMBER)
RIVS Vascular AccessSummary of Major Complications0 participants
Conventional Vascular AccessSummary of Major Complications0 participants
Secondary

Second Stick Success Rate

A secured flushed IV will be indicative of a successful PIV placement.

Time frame: An access attempt usually ranges from 0 to 45 minutes in duration.

Population: Number of Participants Analyzed is not consistent with numbers provided in the Participant Flow Module because not all participants required a second attempt at catheter placement.

ArmMeasureValue (NUMBER)
RIVS Vascular AccessSecond Stick Success Rate10 participants
Conventional Vascular AccessSecond Stick Success Rate18 participants
p-value: 0.8Fisher Exact
Secondary

Summary of Minor Complications

Any device-related or procedure-related adverse event that causes clinically inconsequential symptoms to the patient.

Time frame: Post-PIV placement until catheter removal (usually within 4 days)

ArmMeasureValue (NUMBER)
RIVS Vascular AccessSummary of Minor Complications1 participants
Conventional Vascular AccessSummary of Minor Complications0 participants
Secondary

Time Required to Obtain Access

A secured flushed IV will be indicative of a successful PIV placement.

Time frame: An access attempt usually ranges from 0 to 45 minutes in duration.

ArmMeasureValue (MEAN)Dispersion
RIVS Vascular AccessTime Required to Obtain Access4.0 minutesStandard Deviation 4
Conventional Vascular AccessTime Required to Obtain Access5.0 minutesStandard Deviation 5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026